ASCML
IBB icon

ADKINS SEALE CAPITAL MANAGEMENT LLC’s iShares Biotechnology ETF IBB Stock Holding History

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125K Hold
655
– – 0.11% 108
2026
Q1 		$111K Hold
655
– – 0.11% 104
2025
Q4 		$111K Buy
+655
New +$106K 0.11% 103

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ADKINS SEALE CAPITAL MANAGEMENT LLC's IBB Position: Q2 2026 in Review

ADKINS SEALE CAPITAL MANAGEMENT LLC held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 655 shares worth $125K. The position accounts for 0.11% of the portfolio, ranked #108.

ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. 560 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • ADKINS SEALE CAPITAL MANAGEMENT LLC held 655 shares of iShares Biotechnology ETF worth $125K as of Q2 2026.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.11% of ADKINS SEALE CAPITAL MANAGEMENT LLC's portfolio in Q2 2026, its #108 holding.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • 560 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on ADKINS SEALE CAPITAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 5 Aug 2026.